← SynDRA
OXAMNIQUINE
SynDRA canonical compound SYN0002182 — structure-anchored drug synonym record
| Clinical phase | Withdrawn |
| Approval status | Approved · OTC |
| Mechanism of action | dna inhibitor |
| Indication | schistosomiasis |
| Disease area | infectious disease |
Mechanisms of action (all sources)
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- DRD3
- DRD2
- ADORA1
- HRH2
- HTR1A
- HTR2A
- HTR2B
- HTR2C
- HTR3A
- KCNH2
- MAOA
- MBNL1
- MC3R
- MC4R
- MLNR
- NPY1R
- NR1I2
- NR3C1
- OPRD1
- OPRK1
- OPRM1
- PDE3A
- PDE4D
- PGR
- PTGS2
- SLC29A1
- SLC6A2
- SLC6A3
- SLC6A4
- HRH3
- HRH1
- ADORA2A
- CCKAR
- ADORA3
- ADRA1A
- ADRA2A
- ADRA2B
- ADRA2C
- ADRB1
- ADRB2
Drug classes
- Anthelmintic
- Anthelmintics
- Anti-Infective Agents
- Antiparasitic Agents
- Antiplatyhelmintic Agents
- Schistosomicides
ATC classes
Cross-references
Synonyms
- VANSIL
- (+/-)-Oxamniquine
- UK-4271
- Oxamniquina
- Oxamniquinum
- NSC-352888
- UK-4261
- Mansil
- Vansil
- Oxaminiquine
- UK 4261
- Mansil (TN)
- Oxamniquina [INN-Spanish]
- Oxamniquinum [INN-Latin]
- Vansil (TN)
- Oxamniquine (USAN/INN)
- Oxamniquine [USAN:BAN:INN]
- UK 4271
- NSC 352888
- 0O977R722D
- DTXCID803398
- Oxamniquinum (INN-Latin)
- Oxamniquina (INN-Spanish)
- UK4271
- RefChem:56479
- CHEBI:7819
- P02BA02
- (+)-Oxamniquine
- Oxamniquine, (+)-
- Oxamniquine, (-)-
- MLS000756891
- 7GIJ138H3K
- NSC352888
- OXAMNIQUINE(200MG)DISCONTINUED
- CCRIS 4113
- HSDB 6510
- NCGC00016755-01
- EINECS 244-556-4
Look up OXAMNIQUINE in the interactive SynDRA portal →